Incyte Posts 25 Percent Jump in Q1 Revenues; Net Losses Beat Expectations | GenomeWeb

NEW YORK, April 25 - Incyte Genomics earned revenues of $51 million for the first quarter of 2001, up 25 percent from the same period a year ago, the company reported Wednesday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: global genetic diversity map, and more.

The Nuffield Council on Bioethics identifies ethical questions to explore surrounding genome editing.

In a blog post, Brigham and Women's Hospital's Robert Green discusses "predispositional personal genome sequencing."

Stat News reports that there's muted opposition to the Kuwaiti DNA database law.